These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 11261523)

  • 21. Brand name versus generic warfarin: a systematic review of the literature.
    Dentali F; Donadini MP; Clark N; Crowther MA; Garcia D; Hylek E; Witt DM; Ageno W;
    Pharmacotherapy; 2011 Apr; 31(4):386-93. PubMed ID: 21449627
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Evaluation of the clinical and economic impact of a brand name-to-generic warfarin sodium conversion program.
    Witt DM; Tillman DJ; Evans CM; Plotkin TV; Sadler MA
    Pharmacotherapy; 2003 Mar; 23(3):360-8. PubMed ID: 12627935
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Therapeutic equivalence of antipsychotics and antidepressants - A systematic review.
    Cessak G; Rokita K; Dąbrowska M; Sejbuk-Rozbicka K; Zaremba A; Mirowska-Guzel D; Bałkowiec-Iskra E
    Pharmacol Rep; 2016 Apr; 68(2):217-23. PubMed ID: 26922520
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Intrapatient variation in antiepileptic drug plasma concentration after generic substitution vs stable brand-name drug regimens.
    Contin M; Alberghini L; Candela C; Benini G; Riva R
    Epilepsy Res; 2016 May; 122():79-83. PubMed ID: 26987080
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Branded versus generic clozapine for treatment of schizophrenia.
    Makela EH; Cutlip WD; Stevenson JM; Weimer JM; Abdallah ES; Akhtar RS; Aboraya AS; Gunel E
    Ann Pharmacother; 2003 Mar; 37(3):350-3. PubMed ID: 12639161
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Plasma clozapine and norclozapine in patients prescribed different brands of clozapine (Clozaril, Denzapine, and Zaponex).
    Couchman L; Morgan PE; Spencer EP; Johnston A; Flanagan RJ
    Ther Drug Monit; 2010 Oct; 32(5):624-7. PubMed ID: 20720516
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Generic switch after ramipril patent expiry is not associated with decreased pharmacy refill compliance: a retrospective study using the DAPI database.
    Ude M; Schuessel K; Quinzler R; Leuner K; Müller WE; Schulz M
    J Hypertens; 2011 Sep; 29(9):1837-45. PubMed ID: 21738055
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Comparison of Preparation Efficiency and Therapeutic Safety between Brand-Name and Generic Products of Pemetrexed].
    Tatsuta R; Sumimoto T; Shiraiwa K; Nakahara R; Tanaka R; Itoh H
    Gan To Kagaku Ryoho; 2024 Jun; 51(6):637-641. PubMed ID: 39009522
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Loss of response after switching from brand name to generic formulations: three cases and a discussion of key clinical considerations when switching.
    Margolese HC; Wolf Y; Desmarais JE; Beauclair L
    Int Clin Psychopharmacol; 2010 May; 25(3):180-2. PubMed ID: 20216221
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Prediction of systemic exposure of ketoprofen tapes by in vitro release test and pharmacokinetic model analysis: comparison between brand-name and generic formulations].
    Awa K; Satoh H; Hori S; Sawada Y
    Yakugaku Zasshi; 2012; 132(1):135-44. PubMed ID: 22214588
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The comparison of brand-name and generic formulations of venlafaxine: a therapeutic drug monitoring analysis.
    Unterecker S; Proft F; Riederer P; Lauer M; Deckert J; Pfuhlmann B
    Ther Drug Monit; 2014 Apr; 36(2):269-72. PubMed ID: 24365982
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of propranolol on pharmacokinetics of clozapine in schizophrenic patients: a meta-analysis.
    Yang X; Yan Q; Yang L; Li J; Fan X; Chen J; Wu H; Yang Y; Zhu R; Fang P
    Eur J Clin Pharmacol; 2024 Aug; 80(8):1181-1187. PubMed ID: 38639762
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparing recurrent antibiotic prescriptions in children treated with a brand name or a generic formulation.
    Piovani D; Clavenna A; Cartabia M; Bortolotti A; Fortino I; Merlino L; Bonati M
    Pharmacoepidemiol Drug Saf; 2015 Feb; 24(2):121-8. PubMed ID: 24910387
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cisplatin-induced hyponatremia in malignancy: comparison between brand-name and generic formulation.
    Ochi N; Yamane H; Hotta K; Fujii H; Isozaki H; Honda Y; Yamagishi T; Kubo T; Tanimoto M; Kiura K; Takigawa N
    Drug Des Devel Ther; 2014; 8():2401-8. PubMed ID: 25584019
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Resource use and cost implications of switching among warfarin formulations in atrial fibrillation patients.
    Kwong WJ; Kamat S; Fang C
    Ann Pharmacother; 2012 Dec; 46(12):1609-16. PubMed ID: 23150608
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Bioequivalence and in vitro antimicrobial activity between generic and brand-name levofloxacin.
    Sun HY; Liao HW; Sheng MH; Tai HM; Kuo CH; Sheng WH
    Diagn Microbiol Infect Dis; 2016 Jul; 85(3):347-351. PubMed ID: 27181716
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Evaluation of Switch-to-Brand Rates as a Potential Signal for Therapeutic Equivalency of Generic Antidepressants: A Real-World Retrospective Cohort Study.
    Kalaria S; Spence O; Hong K; dosReis S; Gopalakrishnan M
    Clin Pharmacol Ther; 2021 Aug; 110(2):443-451. PubMed ID: 33811324
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Increasing psychosis in a patient switched from clozaril to generic clozapine.
    Alvarez CA; Mascarenas C; Timmerman I
    Am J Psychiatry; 2006 Apr; 163(4):746. PubMed ID: 16585457
    [No Abstract]   [Full Text] [Related]  

  • 39. A comparison between senior medical students' and pharmacy pre-registrants' knowledge and perceptions of generic medicines.
    Hassali MA; Kong DC; Stewart K
    Med Educ; 2007 Jul; 41(7):703-10. PubMed ID: 17614892
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Are brand-name and generic warfarin interchangeable? A survey of Ontario patients and physicians.
    Pereira JA; Holbrook AM; Dolovich L; Goldsmith C; Thabane L; Douketis JD; Crowther M; Bates SM; Ginsberg JS
    Can J Clin Pharmacol; 2005; 12(3):e229-39. PubMed ID: 16278495
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.